Investing in Axonics (NASDAQ:AXNX) Five Years Ago Would Have Delivered You a 313% Gain
Investing in Axonics (NASDAQ:AXNX) Five Years Ago Would Have Delivered You a 313% Gain
Buying shares in the best businesses can build meaningful wealth for you and your family. While not every stock performs well, when investors win, they can win big. To wit, the Axonics, Inc. (NASDAQ:AXNX) share price has soared 313% over five years. This just goes to show the value creation that some businesses can achieve. It's also good to see the share price up 20% over the last quarter. But this move may well have been assisted by the reasonably buoyant market (up 15% in 90 days).
購買最佳企業的股票可以爲您和您的家人創造有意義的財富。儘管並非每隻股票都表現良好,但當投資者獲勝時,他們可以大獲全勝。換句話說,Axonics, Inc.(納斯達克股票代碼:AXNX)的股價在五年內飆升了313%。這只是表明一些企業可以實現的價值創造。股價在上個季度上漲了20%也是件好事。但是,這一舉措很可能得到了相當活躍的市場(90天內上漲了15%)的推動。
So let's investigate and see if the longer term performance of the company has been in line with the underlying business' progress.
因此,讓我們調查一下,看看公司的長期表現是否與基礎業務的進展一致。
Given that Axonics didn't make a profit in the last twelve months, we'll focus on revenue growth to form a quick view of its business development. Generally speaking, companies without profits are expected to grow revenue every year, and at a good clip. That's because it's hard to be confident a company will be sustainable if revenue growth is negligible, and it never makes a profit.
鑑於Axonics在過去十二個月中沒有盈利,我們將專注於收入增長,以快速了解其業務發展。一般而言,沒有利潤的公司預計每年收入將增長,而且速度很快。那是因爲如果收入增長可以忽略不計,而且從來沒有盈利,就很難確信一家公司能否實現可持續發展。
For the last half decade, Axonics can boast revenue growth at a rate of 55% per year. That's well above most pre-profit companies. Fortunately, the market has not missed this, and has pushed the share price up by 33% per year in that time. It's never too late to start following a top notch stock like Axonics, since some long term winners go on winning for decades. On the face of it, this looks lke a good opportunity, although we note sentiment seems very positive already.
在過去的五年中,Axonics可以以每年55%的速度實現收入增長。這遠高於大多數盈利前公司。幸運的是,市場沒有錯過這一點,並在那段時間內將股價每年上漲33%。現在開始關注像Axonics這樣的一流股票永遠不會太晚,因爲一些長期贏家已經持續贏了幾十年。從表面上看,這似乎是一個很好的機會,儘管我們注意到市場情緒似乎已經非常樂觀了。
The company's revenue and earnings (over time) are depicted in the image below (click to see the exact numbers).
公司的收入和收益(隨着時間的推移)如下圖所示(點擊查看確切數字)。
![earnings-and-revenue-growth](https://usnewsfile.moomoo.com/public/MM-PersistNewsContentImage/7781/20240212/0-044c208fa77a3446937d69dc77f4f758-0-db35c27a45724936c8b89f6408cd6862.png/big)
Axonics is well known by investors, and plenty of clever analysts have tried to predict the future profit levels. You can see what analysts are predicting for Axonics in this interactive graph of future profit estimates.
Axonics爲投資者所熟知,許多聰明的分析師都試圖預測未來的利潤水平。在這張未來利潤估計的交互式圖表中,你可以看到分析師對Axonics的預測。
A Different Perspective
不同的視角
Axonics provided a TSR of 18% over the last twelve months. Unfortunately this falls short of the market return. On the bright side, the longer term returns (running at about 33% a year, over half a decade) look better. It may well be that this is a business worth popping on the watching, given the continuing positive reception, over time, from the market. You could get a better understanding of Axonics' growth by checking out this more detailed historical graph of earnings, revenue and cash flow.
在過去的十二個月中,Axonics的股東回報率爲18%。不幸的是,這沒有達到市場回報率。好的一面是,長期回報率(超過五年,每年約33%)看起來更好。鑑於隨着時間的推移,市場持續給予積極的歡迎,這很可能是一項值得關注的業務。通過查看這張更詳細的收益、收入和現金流歷史圖表,你可以更好地了解Axonics的增長。
If you like to buy stocks alongside management, then you might just love this free list of companies. (Hint: insiders have been buying them).
如果你想與管理層一起購買股票,那麼你可能會喜歡這份免費的公司名單。(提示:業內人士一直在購買它們)。
Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on American exchanges.
請注意,本文引用的市場回報反映了目前在美國交易所交易的股票的市場加權平均回報。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
對這篇文章有反饋嗎?對內容感到擔憂?直接聯繫我們。 或者,給編輯團隊 (at) simplywallst.com 發送電子郵件。
Simply Wall St的這篇文章本質上是籠統的。我們僅使用公正的方法根據歷史數據和分析師的預測提供評論,我們的文章無意作爲財務建議。它不構成買入或賣出任何股票的建議,也沒有考慮到您的目標或財務狀況。我們的目標是爲您提供由基本數據驅動的長期重點分析。請注意,我們的分析可能不考慮最新的價格敏感型公司公告或定性材料。簡而言之,華爾街沒有持有任何上述股票的頭寸。